✨ Your Portfolio is fetched and updated from zerodha.
Micro Agriculture

Genomic Valley Biotech Ltd.

GVBL

Market Cap
₹19 Cr.
P/E
48.94

Genomic Valley Biotech Ltd.

  • Genomic Valley
  • Asian Warehousing
  • Tarai Foods
FAQs on Genomic Valley Biotech Ltd. Shareprice

Genomic Valley has given better returns compared to its competitors.
Genomic Valley has grown at ~97.74% over the last 1yrs while peers have grown at a median rate of 34.81%

Genomic Valley is not expensive.
Latest PE of Genomic Valley is 48.94, while 3 year average PE is 112.
Also latest EV/EBITDA of Genomic Valley is 48.77 while 3yr average is 100.

View FAQ's On Business
Growth Table
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Balance Sheet
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Cash Flow
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Quarterly Results
  • Genomic Valley Biotech Ltd.
  • Asian Warehousing
  • Tarai Foods
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Genomic Valley Biotech Ltd. Financials

Balance sheet of Genomic Valley is strong.
It shouldn't have solvency or liquidity issues.

The debt of Genomic Valley is decreasing.
Latest debt of Genomic Valley is -₹0.42 Crs as of Sep-24.
This is less than Mar-24 when it was -₹0.01 Crs.

The profit is oscillating.
The profit of Genomic Valley is ₹0.02 Crs for Mar 2024, ₹0.65 Crs for Mar 2023 and -₹0.01 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Genomic Valley latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech